Browse the evidence

Endurance training-like electrical stimulation selectively activates the AMPK-PGC-1α signaling pathway, which explains adaptations such as mitochondrial biogenesis and fast-to-slow muscle phenotype transformation without inducing muscle hypertrophy.

To improve mitochondrial health and endurance without gaining muscle size, focus on low-intensity, long-duration activities. This activates specific cellular pathways (AMPK) that optimize energy efficiency rather than building muscle mass.

Resistance training-like electrical stimulation selectively activates the PKB-TSC2-mTOR signaling cascade, leading to prolonged activation of translational regulators and increased muscle protein synthesis, resulting in hypertrophy.

To build muscle mass, focus on high-intensity resistance training. This activates specific cellular pathways (mTOR) that drive protein synthesis and muscle growth.

In low-income countries, the cost of meeting the recommended daily intake of five servings of fruits and vegetables consumes a disproportionate share of household income (median 51.97%), rendering the guideline unaffordable for the majority of the population.

If you live in a low-income region, the standard advice to eat five servings of produce daily may be economically impossible. Focus on the most affordable nutrient-dense options available in your local market (often vegetables over fruits in these regions) and prioritize consistency over perfection. Policy-level changes to improve affordability are necessary to make these guidelines achievable.

GLP-1 receptor agonists reduce hospitalizations for heart failure (HHF) by approximately 10-11%, although their effect on heart failure with reduced ejection fraction (HFrEF) is neutral or potentially harmful in small studies.

If you have Type 2 Diabetes and heart failure, GLP-1 RAs can help reduce the risk of being hospitalized for heart failure. However, if you have a specific type of heart failure where the heart muscle is weak (HFrEF), the data is less clear, and you should discuss the risks and benefits with your doctor.

Bariatric surgery is the most efficacious treatment for sustained weight loss and can induce long-term remission of type 2 diabetes in approximately 30% of patients, with Roux-en-Y gastric bypass being potentially more effective than sleeve gastrectomy for T2D remission.

For severe obesity, bariatric surgery is the most effective long-term treatment. It can lead to remission of type 2 diabetes in about 30% of patients and reduces the risk of heart disease and stroke. It is a serious medical intervention, not a cosmetic procedure.

Resting metabolic rate (RMR) is significantly influenced by familial factors, with a heritability estimate of approximately 40-70%, independent of body composition and lifestyle factors.

Your resting metabolic rate is partly determined by your genetics, independent of your weight. This doesn't mean you can't lose weight, but it means you may need to be more precise with your calorie intake and activity levels than someone with a different genetic baseline. Focus on building lean muscle mass, which increases RMR, and use metabolic testing if available to tailor your diet accurately.

High-fat diets, particularly those high in saturated fatty acids, increase oxidative stress and mitochondrial dysfunction, leading to systemic inflammation and insulin resistance.

Reduce excessive consumption of high-fat diets, particularly those high in saturated fats, to mitigate oxidative stress and mitochondrial dysfunction. Be aware that not all fats are equal, but excessive intake contributes to inflammation and insulin resistance.

A glucose disposal rate (GDR) below 5.6 mg/kgFFM+17.7 min during a 120 mU/m2·min hyperinsulinemic-euglycemic clamp identifies insulin resistance with 75% sensitivity and 71% specificity in white populations.

If you are undergoing metabolic testing, ask how your glucose disposal rate is normalized. For standard research clamps using high-dose insulin, a rate below 5.6 mg/kg fat-free mass per minute suggests insulin resistance. For routine clinical care, a HOMA-IR above 5.9, or between 2.8 and 5.9 combined with low HDL (<51 mg/dL), strongly predicts insulin resistance without needing a clamp.

Insulin resistance can be accurately predicted using routine clinical variables (HOMA-IR, HDL, fasting insulin) without performing a hyperinsulinemic-euglycemic clamp.

You do not need a specialized clamp test to screen for insulin resistance. Ask your doctor for a fasting insulin, glucose, and HDL test. If your HOMA-IR is above 5.9, or between 2.8 and 5.9 with low HDL (<51 mg/dL), you likely have insulin resistance.

Healthy aging is associated with an impaired ability to regulate energy intake, specifically through reduced hunger perception and increased post-meal satiation, leading to an inability to compensate for energy deficits and resulting in involuntary weight loss.

If you are older and experiencing unintentional weight loss, do not rely on hunger cues to tell you when to eat, as these signals are biologically impaired. You must eat on a schedule and prioritize energy-dense, palatable foods to maintain weight, as your body will not naturally compensate for missed meals.

Prior endurance or strength training history attenuates the acute phosphorylation of AMPK and Akt signaling pathways in response to divergent exercise stimuli, indicating that chronic adaptation blunts specific early signaling responses to non-habitual training modes.

If you are already well-trained in one type of exercise (e.g., running or weightlifting), switching to a different type (e.g., lifting or running) will not trigger the same intense initial signaling response as a beginner would experience. This does not mean the new exercise is ineffective; your body is simply more efficient. Focus on consistency and progressive overload rather than chasing acute 'burn' or signaling markers, as your adapted muscle handles stress differently.

Consumption of fish and seafood is not significantly associated with the incidence of type 2 diabetes in the general population, though risk varies by geographic location and BMI.

You do not need to eat fish or take fish oil specifically to prevent type 2 diabetes, as current evidence shows no significant overall benefit for diabetes risk. However, fish remains important for heart health. Focus on overall dietary patterns and weight management rather than expecting fish to act as a diabetes shield.

Dietary and circulating levels of Alpha-Linolenic Acid (ALA) show a non-significant trend toward lower diabetes risk, whereas EPA and DHA (from fish or supplements) show no significant association with diabetes incidence.

Taking fish oil (EPA/DHA) supplements or eating more fish does not appear to significantly lower your risk of type 2 diabetes based on this large review. Plant-based ALA (from flax, walnuts) shows a weak, non-significant trend toward benefit. Do not rely on omega-3s for diabetes prevention.

BCAA supplementation does not improve exercise performance, contradicting the hypothesis that BCAAs serve as a significant fuel source during exercise.

Do not buy BCAA supplements expecting them to boost your workout performance. The evidence shows they do not enhance performance when used as fuel.

Elevated expression of the collagen VI alpha-3 chain (COL6A3) in human adipose tissue is associated with increased visceral adipose tissue mass, reduced adipocyte size, and heightened macrophage infiltration and inflammation.

High levels of collagen VI in fat tissue are linked to worse metabolic health, including more belly fat and inflammation. While you cannot directly 'take' collagen VI, understanding that obesity involves structural changes in fat tissue (fibrosis) highlights why simple calorie counting might not address inflammation. Interventions that reduce fibrosis, such as pioglitazone (a prescription drug), may help lower these markers, suggesting that tissue health is as important as weight loss.

Pioglitazone treatment decreases COL6A3 mRNA expression in obese patients with type 2 diabetes, with the magnitude of decrease proportional to baseline expression levels.

For individuals with type 2 diabetes, the medication pioglitazone has been shown to reduce markers of fat tissue fibrosis (COL6A3). This reduction is most pronounced in those with higher baseline levels. This suggests that pioglitazone may help remodel adipose tissue, potentially reducing inflammation. This is a prescription medication and should be discussed with a healthcare provider.

Acute overfeeding leading to weight gain increases COL6A3 mRNA expression in human adipose tissue.

Gaining weight through overfeeding increases the expression of COL6A3, a protein associated with fat tissue fibrosis and inflammation. This suggests that even short-term weight gain can have structural impacts on fat tissue. Maintaining a stable weight may help avoid these structural changes.

Regular snoring is independently associated with a significantly elevated risk of developing type II diabetes, even after adjusting for body mass index and other confounders.

If you snore regularly, especially if it is loud or frequent, you should be aware that it may increase your risk of type 2 diabetes independently of your weight. This is likely due to the stress snoring puts on your body's hormone systems during sleep. Consider discussing your snoring with a doctor, as treatments like CPAP or oral appliances might not only improve sleep quality but also potentially mitigate metabolic risks. Lifestyle changes like weight loss and exercise are still recommended, but addressing the snoring itself is a distinct health priority.

Caloric restriction in humans does not significantly alter DHEA-S levels, contrasting with findings in non-human primates, suggesting species-specific or age-specific differences in the endocrine response to CR.

Do not expect caloric restriction to boost DHEA-S levels in young, healthy adults. While CR improves other metabolic markers, its effect on this specific hormone appears to be null in this demographic, likely because human subjects in studies are younger and undergo CR for shorter periods than the primates where this effect was observed.

Elevated baseline plasma ceramide concentrations are positively associated with an increased risk of incident cardiovascular disease (CVD), including myocardial infarction, stroke, and cardiovascular death.

High plasma ceramide levels are linked to a higher risk of heart attacks, strokes, and cardiovascular death. However, this risk is not fixed; adhering to a Mediterranean diet (enriched with olive oil or nuts) can neutralize the increased risk associated with high ceramide levels, bringing it down to the level of those with low ceramide levels.

In human skeletal muscle disuse atrophy, muscle mass loss is primarily driven by a depression in protein synthesis (both fasted and fed states) rather than an elevation in protein breakdown (proteolysis).

When you immobilize a limb, your muscle shrinks mainly because it stops building protein, not because it actively destroys it. The muscle becomes 'resistant' to the normal building signals from food (amino acids). Therefore, simply trying to stop breakdown (e.g., with anti-catabolic drugs) may be less effective than addressing the failure of synthesis, potentially through mechanical loading or specific nutritional strategies that overcome this 'anabolic resistance', though the paper notes standard amino acid supplementation often fails to rescue this resistance in the short term.

Caffeine intake of 6 mg/kg does not significantly alter total carbohydrate or fat oxidation rates during steady-state exercise, despite changing plasma metabolite profiles.

Don't worry about caffeine changing your body's fuel usage (fat vs. carbs) during exercise. The study shows it doesn't significantly change how much fat or carbs you burn. The performance boost likely comes from feeling less effort and better nervous system function, not from sparing glycogen.

Adherence to a combination of healthy lifestyle behaviors (smoking cessation, high physical activity, and healthy diet) is significantly lower in low- and middle-income countries compared to high-income countries among individuals with prior cardiovascular disease.

For patients with heart disease or stroke, simply knowing healthy behaviors are good is not enough; access and cost are major barriers. In lower-income settings, focus on affordable, locally available healthy food options and recognize that occupational activity may not replace the need for structured leisure-time exercise. Smoking cessation programs should be prioritized, especially in lower-income regions where cessation rates are lowest.

High-protein diets do not enhance weight or fat loss compared to lower-protein diets when total energy intake is strictly fixed.

If you are counting calories strictly, increasing protein won't make you lose more weight than a lower-protein diet with the same calories. The benefit of protein comes from helping you eat less naturally, not from burning more fat directly.